Penny L. Moore

Durban, ZN, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 217 publications

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.

Journal: Cell host & microbe

Published: June 02, 2026

How Vaccinating People Living With HIV May Guide bNAb‑Based Vaccines.

How Vaccinating People Living With HIV May Guide bNAb‑Based Vaccines.

Journal: Journal of the International AIDS Society

Published: April 17, 2026

Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity.

Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity.

Journal: iScience

Published: March 10, 2026

HLA typing of HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1 loci of 226 individuals from three metropolitan areas in South Africa.

HLA typing of HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1 loci of 226 individuals from three metropolitan areas in South Africa.

Journal: Human immunology

Published: January 13, 2026

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Journal: Nature communications

Published: January 06, 2026

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.

Journal: bioRxiv : the preprint server for biology

Published: December 15, 2025

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.

Journal: PLoS pathogens

Published: November 17, 2025

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.

Journal: Journal of virology

Published: November 10, 2025

Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease.

Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease.

Journal: The Journal of infection

Published: October 28, 2025

Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa.

Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa.

Journal: African journal of laboratory medicine

Published: October 08, 2025

Cell-free RNA reveals host and microbial correlates of broadly neutralizing antibody development against HIV.

Cell-free RNA reveals host and microbial correlates of broadly neutralizing antibody development against HIV.

Journal: PLoS pathogens

Published: October 06, 2025

Showing 1-12 of 217

Last Updated: 09/26/2026